ArticlePregnancy (Hoboken, N.J.)2025
Society for Maternal-Fetal Medicine Position Statement: Decriminalization of substance use disorder in pregnancy.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Naloxone Metabolism Associated With Unexpected Noroxymorphone Detected in Urine During Pregnancy.O&G open · 2026Article
- Report: Workshop on maternal mental health, February 11-12, 2024, cosponsored by the American College of Obstetricians and Gynecologists.Pregnancy (Hoboken, N.J.) · 2025Article
- Society for Maternal-Fetal Medicine Special Statement: Checklists for triage and work-up of persons with symptoms suggestive of cardiovascular disease in pregnancy and postpartum.Pregnancy (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Society for Maternal-Fetal Medicine supports evidence-based screening for and treatment of substance use disorder in pregnancy. The Society for Maternal-Fetal Medicine strongly opposes any policies or practices that are aimed toward or result in the punishment or criminalization of substance use in pregnancy, including punitive legislation, routine biologic toxicology testing, and mandated reporting to the family regulation system (e.g., child protective services, child welfare system). The Society for Maternal-Fetal Medicine acknowledges and aims to eliminate the racial and ethnic disparities in which people of color are disproportionately subject to substance use screening and testing, reporting to the family regulation system, and the effects of punitive legislation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.